台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效

生華科

(6492)
可現股當沖
  • 股價
    41.30
  • 漲跌
    ▲0.60
  • 漲幅
    +1.47%
  • 成交量
    122
  • 產業
    上櫃 生技醫療類股
  • 147人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/22 ~ 2024/04/29     後一日»

券商獲利排行 - 2024/04/22 ~ 2024/04/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.55%20.2020.23232040.740.7041.3
  0.93%12.22.110.122321040.940.84141.3
  1.16%9.509.52020040.840.8041.3
  1.47%9091515040.740.7041.3
  0.79%7.4-0.37.71723640.840.840.841.3
  1.63%5.34.21.22864140.741.441.3
  1.71%4.94.30.61764140.741.441.3
  1.40%4.504.578040.740.74141.3
  1.44%4.104.177040.740.7041.3
  0.89%4-0.24.21011140.940.940.741.3
  0.74%3.603.6121204141041.3
  0.47%3.503.51818041.141.1041.3
  0.25%3.3-2.35.6243394141.140.841.3
  0.23%3.23.200343440.940.840.941.3
  1.06%3.13.1007741.140.841.341.3
  1.50%30355040.740.7041.3
  1.47%30.82.245140.940.841.641.3
  1.11%2.70.42.336240.840.740.941.3
  1.67%2.702.744040.640.6041.3
  1.30%2.60.12.645140.740.740.741.3
  1.60%2.602.644040.740.7041.3
  1.28%2.602.655040.840.8041.3
  1.47%2.402.444040.740.7041.3
  0.84%2.402.47704141041.3
  0.72%2.42.20.218741.241.141.441.3
  1.23%20244040.840.8041.3
  1.47%1.801.833040.740.7041.3
  1.43%1.701.733040.740.7041.3
  1.43%1.701.733040.740.7041.3
  1.38%1.71.20.51324140.841.441.3
  1.98%1.601.622040.540.5041.3
  1.31%1.601.633040.840.8041.3
  1.27%1.501.533040.840.8041.3
  1.85%1.501.522040.640.6041.3
  1.18%1.401.433040.840.8041.3
  1.18%1.401.433040.840.8041.3
  1.72%1.401.422040.640.6041.3
  1.72%1.401.422040.640.6041.3
  1.72%1.401.422040.640.6041.3
  1.72%1.401.422040.640.6041.3
  1.66%1.301.322040.640.6041.3
  0.97%1.21.10.2-12341.240.941.541.3
  1.47%1.201.222040.740.7041.3
  1.47%1.201.222040.740.7041.3
  1.47%1.201.222040.740.7041.3
  1.47%1.201.212040.740.741.541.3
  0.49%1.2-0.31.5561414140.741.3
  1.40%1.11.100224140.741.341.3
  1.41%1.101.122040.740.7041.3
  1.35%1.101.122040.840.8041.3

券商虧損排行 - 2024/04/22 ~ 2024/04/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -0.82%-16.70-16.7-500504104141.3
  -1.58%-160-16-2502540.7040.741.3
  -1.47%-12.60-12.6-2102140.7040.741.3
  -1.59%-11.60-11.6-1801840.7040.741.3
  -0.89%-11.30.6-11.9-2833140.940.740.941.3
  -0.87%-5-0.5-4.5-131144141.54141.3
  -1.72%-4.90-4.9-70740.6040.641.3
  -1.49%-4.80-4.8-80840.7040.741.3
  -1.47%-4.20-4.2-70740.7040.741.3
  -1.87%-3.80-3.8-50540.5040.541.3
  -0.50%-3.7-2.6-1.1-2161840.940.940.841.3
  -0.83%-3.40-3.4-100104104141.3
  -1.12%-3.20.1-3.3-61740.740.640.741.3
  -1.27%-3.10-3.1-60640.8040.841.3
  -1.47%-30-3-50540.7040.741.3
  -1.47%-30-3-50540.7040.741.3
  -1.98%-2.40-2.4-30340.5040.541.3
  -1.47%-2.40-2.4-40440.7040.741.3
  -1.47%-2.40-2.4-40440.7040.741.3
  -1.93%-2.30-2.3-30340.5040.541.3
  -1.41%-2.30-2.3-40440.7040.741.3
  -1.38%-2.30-2.3-40440.7040.741.3
  -1.35%-2.20-2.2-40440.8040.841.3
  -0.73%-2.10-2.1-7074104141.3
  -0.79%-2-2.20.216540.941.140.741.3
  -0.66%-1.90-1.9-7074104141.3
  -0.21%-1.9-3.92822134141.140.841.3
  -1.13%-1.8-0.4-1.4-31440.941.340.841.3
  -1.47%-1.80-1.8-20340.74140.741.3
  -0.73%-1.80.1-1.9-42640.840.840.841.3
  -0.13%-1.8-6.85.122341240.941.140.541.3
  -1.43%-1.70-1.7-30340.7040.741.3
  -0.78%-1.6-0.7-0.9-23540.941.140.841.3
  -0.98%-1.60-1.6-40440.9040.941.3
  -0.76%-1.50.2-1.7-32540.740.640.741.3
  -1.23%-1.50-1.5-30340.8040.841.3
  -0.73%-1.50-1.5-5054104141.3
  -0.89%-1.40-1.4-40440.9040.941.3
  -1.72%-1.40-1.4-20240.6040.641.3
  -1.72%-1.40-1.4-20240.6040.641.3
  -1.10%-1.3-0.2-1.2-21340.840.940.741.3
  -1.60%-1.30-1.3-20240.7040.741.3
  -1.60%-1.30-1.3-20240.7040.741.3
  -0.62%-1.3-1.3005540.740.940.641.3
  -1.02%-1.20-1.2-20340.94140.941.3
  -1.52%-1.20-1.2-20240.7040.741.3
  -0.24%-1.20-1.21212041.441.4041.3
  -1.47%-1.20-1.2-20240.7040.741.3
  -0.98%-1.20-1.2-30340.9040.941.3
  -0.22%-1.10.9-2.1-1121341.140.741.141.3
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-14天前
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科泛病毒感染肺炎新藥 向美申請二期臨床Anue鉅亨-2023/10/19
生華科 相關文章
生華科 相關影音